Cystoscopy Revisited as the Gold Standard for Detecting Bladder Cancer Recurrence: Diagnostic Review Bias in the Randomized, Prospective CEFUB TrialMadelon N.M. van der Aa, Theodorus van der Kwast, Ewout W. Steyerberg et al.|The Journal of Urology|2009Cited by 126
Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 ConsortiumMieke Van Hemelrijck, Michael Fahey, Caroline M. Moore et al.|European Urology|2018Cited by 93
A methylation assay for the detection of non‐muscle‐invasive bladder cancer (NMIBC) recurrences in voided urineTahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Willemien Beukers et al.|British Journal of Urology|2011Cited by 68
Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular MarkersChris H. Bangma, Monique J. Roobol, Stacy Loeb et al.|European Urology|2013Cited by 58
Optimization of Nonmuscle Invasive Bladder Cancer Recurrence Detection Using a Urine Based <i>FGFR3</i> Mutation AssayTahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Stephen S. Tjin et al.|The Journal of Urology|2011Cited by 45